Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study

BACKGROUND: Second line anti-tuberculosis drugs are substantially complex, long term, more costly, and more toxic than first line anti-tuberculosis drugs. In Ethiopia, evidence on the incidence and predictors of adverse drug events has been limited. Thus, this study aimed at assessing incidence and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Infect Dis
Main Authors: Merid, Mehari Woldemariam, Gezie, Lemma Derseh, Kassa, Getahun Molla, Muluneh, Atalay Goshu, Akalu, Temesgen Yihunie, Yenit, Melaku Kindie
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437856/
https://ncbi.nlm.nih.gov/pubmed/30917788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-019-3919-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares